Method for supporting memory function and/or cognitive function

The invention pertains to the use of therapeutically effective amounts of (a) (i) vitamin C and/or selenium and (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA)and docosapentaenoic acid (22:5; DPA), or esters thereof; or (b) (i) vitamin C and/or selenium and (...

Full description

Saved in:
Bibliographic Details
Main Author N V NUTRICIA
Format Patent
LanguageChinese
English
Published 21.12.2018
Subjects
Online AccessGet full text

Cover

More Information
Summary:The invention pertains to the use of therapeutically effective amounts of (a) (i) vitamin C and/or selenium and (ii) at least one of docosahexaenoic acid (22:6; DHA), eicosapentaenoic acid (20:5; EPA)and docosapentaenoic acid (22:5; DPA), or esters thereof; or (b) (i) vitamin C and/or selenium and (iii) one or more of uridine and cytidine, or salts, phosphates, acyl derivatives or esters thereof;or (c) a combination of (i), (ii) and (iii); wherein (a), (b) or (c) optionally further comprises vitamin E, in the manufacture of a product for therapeutically improving synaptic connectivity and/ortherapeutically supporting memory and/or cognitive function in a human subject in need thereof. 本发明涉及治疗有效量的以下物质在制备用于治疗性改善对其需要的人类受试者的突触连接和/或治疗性支持对其需要的人类受试者的记忆和/或认知功能的产品中的用途:(a)(i)维生素C和/或硒和(ii)二十二碳六烯酸(22:6;DHA)、二十碳五烯酸(20:5;EPA)和二十二碳五烯酸(22:5;DPA)或其酯中的至少种;或(b)(i)维生素C和/或硒和(iii)尿苷和胞苷或盐、磷酸盐、酰基衍生物或其酯的种或多种;或(c)(i)、(ii)和(iii)的结合;其中(a)、(b)或(c)任选地还包含维生素E。
Bibliography:Application Number: CN20178028115